IGC Pharma, Inc. (IGC)
0.2815
-0.01
(-2.93%)
USD |
NYAM |
May 28, 16:00
0.2815
0.00 (0.00%)
After-Hours: 16:13
IGC Pharma EPS Diluted (Quarterly) : -0.0245 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NRX Pharmaceuticals, Inc. | -0.0442 |
| NeOnc Technologies Holdings, Inc. | -0.3786 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.402M |
| Revenue (Quarterly) | 0.317M |
| Total Expenses (Quarterly) | 2.719M |
| Enterprise Value | 29.72M |
| Gross Profit Margin (Quarterly) | 4.10% |
| Profit Margin (Quarterly) | -757.7% |
| Earnings Yield | -18.54% |